BlackRock Japan’s Amicus Therapeutics FOLD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-631
Closed -$5K 1329
2016
Q3
$5K Buy
631
+239
+61% +$1.61K ﹤0.01% 1251
2016
Q2
$2K Hold
392
﹤0.01% 1395
2016
Q1
$3K Sell
392
-276
-41% -$1.96K ﹤0.01% 1392
2015
Q4
$6K Sell
668
-484
-42% -$4.36K ﹤0.01% 1314
2015
Q3
$16K Buy
1,152
+232
+25% +$3.64K ﹤0.01% 1119
2015
Q2
$13K Buy
+920
New +$11.1K ﹤0.01% 1243
2014
Q4
Sell
-4,988
Closed -$30K 1336
2014
Q3
$30K Buy
+4,988
New +$26.1K ﹤0.01% 1114

Other funds holding FOLD

BlackRock Japan's FOLD Position: Q4 2016 in Review

BlackRock Japan sold out of Amicus Therapeutics (FOLD) in Q4 2016, closing a stake of 631 shares — an estimated $5K sold.

BlackRock Japan first reported a position in FOLD in Q3 2014 and held it in 7 quarters. The position peaked at $30K in Q3 2014. 135 funds tracked by Wall St. Rank hold FOLD as of Q4 2016.

  • BlackRock Japan reported no remaining Amicus Therapeutics position as of Q4 2016 after selling out during the quarter.
  • BlackRock Japan sold 631 Amicus Therapeutics shares in Q4 2016, an estimated $5K.
  • BlackRock Japan first reported a position in Amicus Therapeutics in Q3 2014 and held it in 7 quarters.
  • BlackRock Japan's Amicus Therapeutics position peaked at $30K in Q3 2014.
  • 135 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q4 2016.

Based on BlackRock Japan's 13F filing for Q4 2016, filed 10 Feb 2017.